VANCOUVER, BC – iCo Therapeutics Inc. (TSXV: ICO) (OTC: ICOTF) (“iCo” or the “Company”) is pleased to announce that it has closed its previously announced private placement (the “Financing”) in… Read More
Vancouver, BC – April 27, 2021 – InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (Nasdaq:INM) (TSX:IN), a clinical-stage company developing cannabinoid-based pharmaceutical drug candidates and leading the clinical development of cannabinol (“CBN”),… Read More
VANCOUVER, BC – InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (Nasdaq: INM; TSX:IN), a clinical-stage company developing cannabinoid-based pharmaceutical drug candidates and leading the clinical development of cannabinol (“CBN”), today… Read More
Vancouver, British Columbia–(Newsfile Corp. – April 23, 2021) – iCo Therapeutics Inc. (TSXV: ICO) (OTCQB: ICOTF) (“iCo” or the “Company”) is pleased to announce that, in connection with its proposed… Read More
April 21, 2021 – bioLytical Laboratories is recruiting local participants for a study in support of their new 1 minute antibody test for COVID-19. Participants need to have been tested… Read More
